Accéder au contenu
Merck

Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice.

The Journal of clinical investigation (2019-05-08)
Daniel L Galvan, Jianyin Long, Nathanael Green, Benny H Chang, Jamie S Lin, Paul Schumacker, Luan D Truong, Paul Overbeek, Farhad R Danesh
RÉSUMÉ

Phosphorylation of Dynamin-related protein1 (Drp1) represents an important regulatory mechanism for mitochondrial fission. Here we established the role of Drp1 Serine 600 (S600) phosphorylation on mitochondrial fission in vivo, and assessed the functional consequences of targeted elimination of the Drp1S600 phosphorylation site in progression of diabetic nephropathy (DN). We generated a knockin mouse in which S600 was mutated to alanine (Drp1S600A). We found that diabetic Drp1S600A mice exhibited improved biochemical and histological features of DN along with reduced mitochondrial fission and diminished mitochondrial ROS in vivo. Importantly, we observed that the effect of Drp1S600 phosphorylation on mitochondrial fission in the diabetic milieu was stimulus- but not cell type-dependent. Mechanistically, we showed that mitochondrial fission in high glucose conditions occurs through concomitant binding of phospho-Drp1S600 with mitochondrial fission factor (Mff) and actin-related protein 3 (Arp3), ultimately leading to accumulation of F-actin and Drp1 on the mitochondria. Taken together, these findings establish that a single phosphorylation site in Drp1 can regulate mitochondrial fission and progression of DN in vivo, and highlight the stimulus-specific consequences of Drp1S600 phosphorylation on mitochondrial dynamics.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Protein A-Sepharose CL-4B, Cytiva 17-0780-01, pack of 1.5 g